This phenomenon was also observed in mutant CTNNB1;MYC samples from patients with HCC (Extended Data Fig. 4d), suggesting that synergistic WNT pathway and MYC mutations can confer both proliferative and anti-apoptotic benefits in liver tumorigenesis. Here, CTNNB1 is linked to hepatocellular carcinoma.